Om

Jiangxi Institute of Biological Products Inc. Class H is a China-based biotechnology and biopharmaceutical company specializing in antitoxin and immune-serum biological products. The firm focuses on the research, development, manufacturing, and sale of human tetanus antitoxin, an antibody-based therapy used for prophylaxis and treatment following potential tetanus exposure, as well as related antiserum vial and ampoule preparations for clinical use. It also produces a range of veterinary medicines, including veterinary tetanus antitoxin, hormone-based products, and other biological formulations, along with active pharmaceutical ingredients, equine byproducts, essential oils, and plant extracts for industrial and healthcare clients. Jiangxi Institute of Biological Products Inc. serves hospital, clinic, and pharmaceutical customers in China and multiple international markets, supplying both finished dosage forms and bulk biological materials. Founded in 1969 and headquartered in Ji'an, Jiangxi Province, the company today plays a specialized role in the biopharmaceutical supply chain as a key provider of antitoxin and immune-serum solutions for human and animal health.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I JIANGXI INSTITUTE OF BIOLOGICAL PRODUCTS MED ENDAVU: Køb Jiangxi Institute of Biological Products ($6915) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Jiangxi Institute of Biological Products, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.